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Short running title – Virtual Reality for Pain Management
Abstract  
Objective: To evaluate the effectiveness of virtual reality as a distraction technique in the 
management of acute pain and anxiety during outpatient hysteroscopy. 
Design: Parallel group, prospective randomised controlled trial.
Setting: UK University Hospital 
Methods: Forty consenting, eligible women were randomised to virtual reality intervention 
(immersive video content as a distraction method) or standard care during outpatient 
hysteroscopy from August to October 2018.
Main Outcome Measures: Pain and anxiety outcomes were measured as a numeric 
rating score (scale of 0-10). 
Results: Compared to standard care, women with virtual reality intervention experienced 
less average pain (score 6.0 vs. 3.7, mean difference 2.3, 95% CI 0.61-3.99, p=0.009) 
and anxiety (score 5.45 vs. 3.3, mean difference 2.15, 95% CI 0.38-3.92, p=0.02). 
Conclusion: Virtual Reality was effective in reducing pain and anxiety during outpatient 
hysteroscopy in a mixed-methods randomised control trial. Its wide potential role in 
ambulatory gynaecologic procedures needs further evaluation. Funding: Supported by 
NIHR Patient safety Translational Research Centre funding. 
Keywords: Virtual reality, outpatient hysteroscopy, pain, anxiety, Randomised Controlled 
Trial.
Trial Registration: The trial is registered at the US National Institutes of Health 
(ClinicalTrials.gov) #NCT03699280 https://clinicaltrials.gov/ct2/show/NCT03699280
https://clinicaltrials.gov/ct2/show/NCT03699280
Tweetable abstract: Virtual Reality can be used as a part of a multimodal strategy to 
reduce acute pain and anxiety in patients undergoing outpatient hysteroscopy.
Introduction 
Performance of diagnostic and operative procedures for gynaecological conditions in the 
consultation room setting, is becoming increasingly commonplace in order to reduce risks 
of general anaesthetic, decrease health care costs and increase convenience for both 
patient and provider1. Such procedures are usually well tolerated2 but can be associated 
with acute pain and anxiety  3,4 5 6. Pain relief options include sedation, local anaesthetic, 
analgesics and distraction techniques, though no consistent good quality evidence exists 
to underpin practice7 8 9 10 11 12.  
Virtual reality (VR), a relatively new intervention, has been studied as a distraction 
technique for non-pharmacological pain relief. It is a computer-generated representation 
of an immersive environment viewed through a headset 13. The cost, quality and 
accessibility of virtual reality devices has significantly improved in recent years and 
offered novel application in the medical field. Virtual reality for managing pain has been 
studied in paediatrics, dentistry, burns treatment, chronic pain, labour, episiotomy and 
phobias 14–22 23 24. Although a metaanalysis suggested that VR may have a role in 
reducing pain scores in acutely painful procedures, it was found to be effective only in 
needles and burns physical therapy.  The studies of VR on pain and anxiety however 
were limited by clinical and statistical heterogeneity14 25  Nonpharmacological options of 
pain relief have not  explored the role of virtual reality in reducing pain and improving 
patient experience in outpatient hysteroscopy 26. To our knowledge, there are no 
publications studying the effects of Virtual Reality in the management of pain during office 
gynaecological procedures 7  
We conducted a randomised controlled trial of virtual reality intervention as a distraction 
technique, versus standard care, in managing acute pain and anxiety during outpatient 
hysteroscopy.
Methods 
Study design and setting
The study was a single centre, parallel group, prospective randomised controlled trial 
conducted at a large University hospital in London UK from August 2018 to October 2018 
(Whipps Cross University Hospital). The study was approved by the National Research 
Ethics Committee, Health Research Authority and registered as a clinical trial. 
(ClinicalTrials.gov Identifier: NCT03699280). The study was supported by NIHR Patient 
safety Translational Research Centre funding.
Study participants and eligibility criteria
Consecutive women scheduled to undergo an outpatient hysteroscopy were invited to 
participate in the trial. Eligibility criteria included all consenting women 18 – 70 years of 
age with a planned outpatient hysteroscopy. Excluded were any women with hearing or 
visual impairment, or any known anatomical characteristics that makes performing the 
office procedure difficult, e.g. cervical conization, amputation. 
Recruitment, randomisation and follow up
After written informed consent, eligible women were randomly allocated using sealed 
envelopes to either the virtual reality intervention or standard care. Using a secure online 
system, a randomisation scheme based on permuted block of random block sizes (2, 4) 
and stratified by parity (nulliparous, multiparous) and menopausal status 
(premenopausal, post- menopausal), created the allocation sequence. Due to the nature 
of the intervention, blinding of participants, care providers and outcome assessors was 
not possible, but allocation remained concealed until randomisation. 
The intervention group received the virtual reality device with immersive video content for 
the use during their outpatient hysteroscopy as a distraction method. The VR headset 
was shown to the patient after confirming eligibility and prior to recruiting. They were 
given the option of trying the headset on, however the video was played only at the start 
of the procedure. 
In the standard care group, women underwent their outpatient hysteroscopy as a routine 
procedure without offering the virtual reality intervention. Patient follow up was clinically 
indicated, not arranged for the purpose of the trial. 
Outpatient hysteroscopy (standard care)
All procedures were performed in the office setting using a 3.2 mm rigid hysteroscope 
(Stortz Versascope) using normal saline as distension medium. A vaginoscopic technique 
was utilised unless it failed and dilatation was necessary. Patients were instructed to self 
administer analgesics prior to the procedure (either paracetamol or non steroidal anti-
inflammatory drugs). Depending on the indications and findings of the hysteroscopy, 
additional procedures like pipelle biopsies, endometrial biopsies using biopsy forceps, 
polypectomies, Mirena coil insertions or removals were recorded. Intracervical local 
anaesthetic infiltration was administered where necessary in the form of rescue 
analgesia. 
Virtual reality during hysteroscopy (intervention)
Immersive and interactive video content was delivered to patients randomised to the 
virtual reality intervention using an portable, standalone VR headset called Oculus Go 
with a head mounted display with built in audio drivers and cleaned with wipes between 
patients. Disposable hygeine masks were used as an underlay below the headset.
The guided relaxation experience included viewing an 8-minute video called ‘Forest of 
Serenity’ commissioned by St. Giles Hospice, developed by Holosphere and narrated by 
Sir David Attenborough27.  The immersive video simulated a calming rainforest and a 
lake setting with animated wildlife, which could be explored by using the headtracker. The 
video played was one with minimal movement and a familiar voice to achieve maximal 
desired effect. The video was played for the duration of the procedure and replayed when 
the procedure exceeded 8 minutes.  Patients were allowed to stop viewing the video or 
remove the headset at their own discretion or in the event of side effects. There was no 
screening for infectious diseases as a part of the protocol over and above the standard 
infection control procedures clinically required in the NHS. 
Outcomes and measurements
Primary outcome measurements were worst and average pain, based on numeric rating 
scores (11-point scale from 0 to 10; 0 representing ‘no pain/anxiety’ and 10 representing 
‘worst imaginable pain/anxiety’) along with anxiety, recorded pre-procedurally (as 
‘anticipated’ prior to the procedure) and that ‘experienced' during the procedure 28, 29,30. 
‘Worst pain scores’ indicated the most pain experienced during the procedure, even if 
momentary. Data was collected immediately before and after the procedure. Data on the 
proportion of patients eligible, stratification factors (menopausal status and parity) 
consented and randomised, reasons for non-participation, and acceptability of the trial 
and intervention to participants and healthcare providers, were collected. The perception 
of the clinician performing the procedure and the nursing staff regarding feasibility of 
using the virtual reality equipment for each patient who had the intervention was 
assessed through questionnaires. Semi-structured interviews were conducted with 
women who received the virtual reality intervention within 30 minutes of the procedure 
and were recorded on a digital voice recorder. The questions focused on the patient’s 
experience of the hysteroscopy and the intervention, pain and anxiety perceived and also 
any other aspects that they felt were relevant to hospital care. The interviews allowed for 
all participants to be asked similar questions within a flexible framework.31
Interviews continued until no new information was being obtained and theoretical 
saturation point was reached.32 
Sample size and statistical analysis
The target sample size for this trial was 40 (20 per group), based on the weekly number 
of women attending who could be approached (15) and an estimated 60% participation 
rate. There were no prior estimates of standard deviations available for power estimation. 
All data was entered into a secure database and anonymised using participant codes at 
the point of data entry. 
Statistical analysis was by intention-to-treat including all randomised participants, using R 
software Version 3.5.1 (Feather Spray). Continuous data were summarised as mean 
and standard deviation, and categorical data as counts and percentages. Between-
group differences were reported with 95% confidence intervals (CI) and p-value 
(using t test to compare normally distributed data). Cohen’s d, difference in scores 
measured on a standard deviation scale, was used to determine effect size with 
values above 0.7 considered to be large33. Linear regression was used to estimate 
difference in continuous outcomes between groups post-procedure, adjusting for 
stratification factors (of menopausal status and parity). Bonferroni correction was 
applied for multiple testing. 
Patient and public engagement
Prior to the study, the development of the research question was informed by patient’s 
priorities and preferences. Staff and patients were involved in the planning of the study 
and in designing the intervention including the selection of videos for viewing. Patients 
and public representatives were not involved in the recruitment or the conduct of the 
study. Interviews and focus group discussions gathering information on the 
implementation, acceptability and content of the virtual reality videos viewed with clinical 
staff, was done to get an understanding of factors that might influence participation in a 
definitive trial. 
Results
Patient recruitment and characteristics
A total of 53 women were approached for 6 weeks between August 2018 and October 
2018. Of these, 8 declined to participate and 5 did not meet eligibility criteria. Finally, forty 
of 48 (83%) women agreed to participate and were randomised. (Figure 1). Reasons for 
exclusion of the 5 patients included 4 patients being over the age of 70, of which one 
patient had hearing difficulty and 1 patient did not need a hysteroscopy. Eight patients 
declined to participate of which 2 patients wanted to see the procedure, 2 patients had 
used virtual reality before for gaming and were queasy, 2 patients were very anxious 
about the procedure and declined participation, 1 patient couldn’t wait for the procedure 
as there were delays in the clinic and 1 patient had brought her own headphones with an 
audio track to keep herself distracted. All patients completed the procedure except one 
having standard care who did not tolerate the procedure and needed to be booked for an 
outpatient hysteroscopy under general anaesthetic. Data for all 40 patients was 
considered for statistical analysis.
Baseline characteristics (Table 1) show that groups were balanced for features including 
age, parity, menopausal status, previous experience of outpatient hysteroscopy, 
anticipated pain and anxiety scores, and analgesic intake prior to the procedure. Before 
the procedure, the mean pain and anxiety scores anticipated by the patient during the 
procedure were 6.7 and 5.98 respectively and there were no significant differences in 
either score between standard care and virtual reality groups. The procedures were 
performed in a single centre by 4 clinicians of consultant grade and a nurse and a 
healthcare assistant supported the clinics. Vaginoscopic approach was possible in 90% 
(36/40) of all the procedures (19/20 in the VR group and 17/20 in the standard care 
group). In the VR group, 2/20 had cervical stenosis and needed rescue local anaesthetic 
versus 4/20 receiving standard care. Eighteen percentage of the patients (7/40) had an 
experience of an outpatient hysteroscopy in the past and was comparable in the two 
groups. The mean duration of the outpatient hysteroscopy and additional procedures 
performed in the VR group procedure was 3.25 minutes and 0.85min respectively and 
that in the standard care group was 3.8 minutes and 1.75 minutes respectively.
Nausea was experienced by one patient in the virtual reality intervention arm, however 
she kept the headset on until the end of the procedure; one patient had previous history 
of claustrophobia and decided to removed the headset when the procedure started as 
she felt claustrophobic.
Pain and anxiety
Compared to standard care, the virtual reality intervention had a large effect reducing 
worst pain with a 2.2 score difference (28% reduction, score 7.85 vs. 5.65, 95% CI 3.79 – 
3.79, p=0.011, Cohen's d 0.82), average pain with a 2.3 difference (38% reduction, score 
6.0 vs. 3.7, 95% CI 0.61-3.99, p=0.009, Cohen's d 0.81), and anxiety with a 2.15 
difference (39% reduction, scores 5.45 vs. 3.3, 95% CI 0.38-3.92, p=0.024, Cohen's d 
0.73)14 (Table 2, Appendix S1).  
In order to examine whether the observed effects of virtual reality were robust, multiple 
regression models were fitted for each pain and anxiety outcome, to estimate the effect of 
the virtual reality condition, whilst controlling for anticipated pain and anxiety scores, 
parity, menopausal condition and cervical stenosis (Table 3; Appendix S1).  For worst 
pain scores, the virtual reality condition accounted for a 2.11-point decrease in 
experienced pain, compared with the control group (p=0.011; R2=0.24), after controlling 
for covariates.  For average pain scores, a 2.28-point decrease in experienced pain was 
observed (p=0.01; R2=0.24) and for anxiety scores, a 2.13-point decrease (p=0.024; 
R2=0.16) associated with the VR condition compared with control. After applying 
Bonferroni correction for multiple testing, our findings regarding pain and anxiety remain 
significant.
Follow up questionnaire results revealed that all (100%) of the women who received the 
virtual reality intervention were happy to have the procedure again in the outpatient 
setting. Fifteen percent (6/40) women receiving standard care expressed their views that 
they would have liked to have the procedure done under general anaesthetic instead of 
the outpatient setting. 
The gynaecologists performing the procedure reported that the intervention was feasible 
in 90% (18/20) and thought to be helpful for the particular patient in 85%(17/20) of cases. 
The staff nurses assisting the procedure reported that the intervention was feasible in 
85% (17/20) and thought to be helpful for the particular patient in 85%(17/20) of cases
Patient and staff experience
Semi-structured interviews were conducted with patients (16 who received virtual reality 
intervention and 12 patients who had standard care), 2 clinical staff and 3 nursing staff 
(Appendix S2). Thematic analysis of interview transcripts provided rich insights into 
patients’ experience of the VR intervention.  A range of representative quotes from 
patients (Appendix S2) illustrates the possible mechanisms by which virtual reality 
immersion was reported to influence the experience of pain and anxiety.  Positive 
experiences included a sense of relaxation that distracted from pain, as a result of 
calming visual imagery, environmental immersion and narrated soothing metaphors 
about pain control and deflection.  Some patients appreciated the fact that the VR 
headset blocked sight of doctors and equipment that they found particularly anxiety 
provoking.  Although patients generally reported that the VR did not remove their pain 
entirely, they reported that the distraction element helped control pain and immediate 
recovery from instances of sharp pain during the procedure.  In contrast, some patients 
reported no effect of the VR technology on experienced levels of pain or that it was only 
effective during low to moderate pain.  Views were mixed on whether the lack of 
situational awareness of the consultation room was of benefit and some patients 
preferred to be more aware of the procedure or be able to talk unimpeded with the 
doctor.  Qualitative analysis suggested that most patients found the headset to be 
comfortable. A minority of patients reported wearing the VR headset to be uncomfortable 
and claustrophobic, or that the sense of motion in the VR environment induced nausea 
but despite these limitations, the intervention was found to be effective in analysis.. One 
patient in the intervention arm experienced nausea, however she managed to keep the 
headset on till the end suggesting that the symptoms wasn’t severe. Two patients 
declined to participate in the study as they had used VR for gaming and had experienced 
nausea. However the nature of the video used in the intervention was very different from 
the one used in gaming and the fact that the patient is lying down is likely to reduce the 
incidence of nausea whilst viewing the contents on the video. The qualitative analysis 
suggested patient feedback with a suggestion to have a range of videos or a video of a 
virtual hysteroscopy which would educate the patient about the procedure and introduce 
them to the intervention. 
Discussion
Main findings
Compared to standard care, the virtual reality pain management intervention had a large 
effect in reducing pain and anxiety in outpatient hysteroscopy.  This effect was robust, 
after controlling for baseline pain and anxiety expectations and a range of patient 
covariates. Staff and majority of the patients found the procedure to be both feasible and 
acceptable and patients reported a range of experiences, suggestive of the mechanisms 
by which VR technology may influence pain and anxiety via immersion, relaxation, 
distraction and imagery. Qualitative analysis suggested that the headsets were 
reasonably comfortable.
The study additionally demonstrated willingness of patients to participate and identified 
barriers to recruitment, non–participation, compliance or standardisation of healthcare 
providers care pathways through a mixed methods approach using qualitative data to 
draw useful insights complementing the findings from the quantitative analysis, in order to 
support future research and development in this area.  Insights generated from the 
themes suggested offering a multimodal pain relief strategy to improve experience at 
outpatient hysteroscopy. Qualitative analysis suggested patient profiling based on history, 
taking into consideration patient preferences by offering a variety of distraction 
techniques with a range of videos to choose from were they to choose virtual reality as a 
distraction technique. The analysis offered key insights into patient expectations 
concerning the degree of pain relief possible with virtual reality technology and 
implementation strategies to facilitate around transfer of research finding into clinical 
setting.
Strengths and weaknesses
The topic of pain control in gynaecological procedures is a difficult topic to study and a 
significant strength of this study lies in the parallel qualitative investigation of patient 
attitudes and experiences.  The experimental arm of this study achieved a 100% follow-
up rate from baseline and was strengthened through the use of standard methods of 
control, including randomisation, stratification and minimisation techniques ensured 
comparability at baseline and minimising selection bias. Numeric Rating Scale is known 
to be a validated measure of pain, is easy to use, has high compliance rates and detects 
meaningful changes in pain and anxiety25.
One limitation of the intervention was that the video was made from a standing rather 
than prone perspective; the field of vision during hysteroscopy was such that the entire 
content of the virtual environment could not be explored and this might be addressed by 
development in the VR technology. Restriction of movement of the patient whilst 
engaging with the video in light of the nature of the diagnostic procedure could also limit 
the degree of immersion. The duration of the video was shorter than the length of the 
procedure for two patients, requiring the video to be restarted. This disrupted the 
immersion experience and required the health care assistant to keep a watch on when 
the video finished. Despite these limitations, the intervention was found to be effective in 
analysis.
The effect of the intervention is likely to depend on the nature of the video as are the side 
effects like movement induced nausea. The video in the intervention was in a familiar 
voice and was designed to alleviate pain, which may have contributed to the results. 
Although the groups were comparable, there were higher number of patients of cervical 
stenosis in the standard care group (4/20) when compared to the VR group (2/20) which 
may have influenced the outcome. 
The intervention, due to its nature, could not be blinded from the participants, so a 
placebo effect related to self-reporting of outcome scores may have influenced the 
results. Non-blinding of the participants could have resulted in patients receiving the VR 
intervention underreporting the pain and anxiety scores and those patients not receiving 
the intervention to have over-reported the scores. Additionally, the pain and anxiety 
scores were measured within 10 minutes of the intervention and were therefore subject to 
a degree of recall bias. As prior estimates of standard deviation were not available, 
powering the study for any expected effect size was not possible. No formal power 
calculation was performed. However, we detected a relatively large significant difference 
between groups and therefore avoided the risk of a type 2 error. Our findings will inform 
sample size calculations for a future full-scale trial. 
To our knowledge, this is the first randomised evaluation of feasibility, effectiveness and 
acceptability of a virtual reality intervention in gynaecology. However, a trial protocol has 
been published for a randomised controlled trial for VR analgesia for women during 
hysterosalpingograms and results will be forthcoming.34 
Interpretation of findings
Ensuring adequate pain relief and allaying anxiety during outpatient hysteroscopy can be 
challenging and can impact women’s satisfaction with the experience. Appropriate patient 
selection, counselling and adequate pain management during the procedure can improve 
patient experience, reduce the number of failed procedures, and improve safety, 
accuracy and effectiveness of the procedure. 
There is a lack of consensus on the choice of analgesia for outpatient hysteroscopy 9 with 
a recent metaanalysis and systematic review suggesting oral NSAIDS and TENS for pain 
relief.35 Despite this, there has been limited research into the role of distraction 
techniques in the management of pain and anxiety in ambulatory gynaecological 
procedures with no published studies on virtual reality as a pain relief modality.26 
Nonpharmacological options of pain relief at outpatient hysteroscopy include music 36,37, 
hypnosis, vaginoscopic methods of hysteroscopy,38 adjusting the temperature and 
pressure of distension medium, stretching of the uterus with a full bladder and electricity 
via TENS 26 watching the screen39 , conversation with positive suggestion and guided 
imagery. Our study provides new evidence that VR distraction techniques could be used 
in future to enhance the range of pain relief options. 
Our qualitative findings are suggestive of the psychological mechanisms by which VR 
reduces pain but further research is needed in this area. Interaction with VR uses a 
substantial amount of the patient’s limited controlled attentional resources.40. 41  42. By 
virtue of spending lesser time thinking about the procedure by distracting the patients, the 
intervention may operate to reduce pain scores.
From a service implementation perspective, insights generated from the themes 
suggested offering a multimodal pain relief strategy to improve experience at outpatient 
hysteroscopy. Qualitative analysis suggested patient profiling based on history, taking 
into consideration patient preferences by offering a variety of distraction techniques with 
a range of videos to choose from were they to choose virtual reality as a distraction 
technique. The analysis offered key insights around managing patient expectations 
around the degree of pain relief with virtual reality and implementation strategies around 
transferring research finding into clinical setting. 
The study showed a large sized reduction in scores in pain or anxiety with virtual reality, 
even though it is unlikely to eliminate pain completely. The intervention was well tolerated 
with no serious side effects. It would be useful to compile core outcome sets based on 
patient reported outcomes for pain and anxiety towards future research in ambulatory 
gynaecological procedures. Algorithmic prediction of the types of patients who would 
benefit most from the intervention should also be modelled in future trials based on 
patient characteristics, baseline pain and anxiety scores and a past history of 
claustrophobia for planning a multimodal analgesic strategy.
The type of VR equipment and the degree of interaction with the video is likely to effect 
the analgesic effectiveness.19 Virtual reality is an evolving technology and designing 
appropriate content of the video with adequate duration, headsets and hygiene masks to 
comply with infection control protocols and also have affordances and good aesthetics 
that make it comfortable to wear would be paramount prior to clinical adoption, which 
would need codesign with patients and manufacturers. It would be appropriate to have a 
range of videos for the patient to choose from, which might be with our without narration. 
Other avenues include using virtual reality for patient education for familiarisation with the 
procedure and using it as a triage prior to offering it as an intervention for pain relief.
Conclusions
Immersive virtual reality intervention is feasible, effective and acceptable in a clinical 
setting as a distraction technique for the management of pain and anxiety in patients 
undergoing outpatient hysteroscopy. This study demonstrated a robust effect for VR 
technology in this application, within a relatively small-scale trial. Future development of 
VR technologies for this application, coupled with larger-scale trials, would strengthen the 
evidence-base for alternative pain management interventions in ambulatory gynaecology. 
Transferability of these findings into the clinical setting needs to be evaluated by future 
trials and economic evaluations of additional costs of equipment and training.
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Table 1. Baseline characteristics of participants in standard care and virtual reality
Characteristic
Standard care 
(n = 20) 
Mean (SD) or n (%)
Virtual reality 
(n = 20) 
Mean (SD) or n (%)
Age (years) 31.3 (5.2) 31.1 (5.4)
Parity (No.) 2.2 (1.9) 2.4 (1.7)
Nulliparous 4 (20) 4 (20)
Multiparous 16 (80) 16 (80)
Ethnicity
White 8 (40) 9 (45)
Black 4 (20) 3 (15)
Asian 5 (25) 8 (40)
Mixed 3 (15) 0 (0)
Menopausal status
Pre-menopausal 7 (35) 7 (35)
Post-menopausal 13(65) 13(65)
Prior outpatient hysteroscopy 3 (15) 4 (20)
Hysteroscopy indication
Heavy Menstrual Bleeding 5 (25) 6 (30)
Incidental finding 2 (10) 5 (25)
Postmenopausal bleeding 11 (55) 8 (40)
Lost coil thread 2 (10) 0 (0)
Recurrent postcoital bleeding 0 (0) 1 (5)
Pain killers taken before procedure 12 (60) 13(65)
Pain score anticipated by patient 6.5 (2.0) 7.0 (2.2)
Anxiety score anticipated by the patient 5.6 (3.1) 6.4 (2.9)
Table 2. Comparison of experienced pain and anxiety between standard care and 
virtual reality intervention in the Trial






Standard Care 20 7.85 (2.56) 6.65 ,9.05
Virtual Reality 20 5.65 (2.41) 4.52, 6.78
Difference 2.20 3.79 0.01 0.008
Average Pain Scores
Standard Care 20 6 (2.62) 4.78, 7.22
Virtual Reality 20 3.7 (2.66) 2.46, 4.94
Difference 2.3 0.61, 3.99 0.01 0.009
Anxiety Scores
Standard Care 20 5.45 (3.35) 3.88, 7.02
Virtual Reality 20 3.3 (2.03) 2.35, 4.25
Difference 2.15 0.38, 3.92 0.02 0.019
Figure 1: Patient recruitment in the trial. 
 
 
Assessed for eligibility (n= 53) 
Excluded  (n= 13) 
♦  Not meeting inclusion criteria (n= 5)
♦ Declined to participate (n= 8)
Analysed  (n=20) 
♦ Excluded from analysis (n=0)
Lost to follow-up (n=0) 
Discontinued intervention (n=1) 
Allocated to standard care (n= 20) 
♦ Received allocated intervention (n=20)
♦ Did not receive allocated intervention (n=0)
Lost to follow-up (n=0) 
Discontinued intervention (claustrophobic) 
(n=1) 
Allocated to intervention (n=20) 
♦ Received allocated intervention (n=20)
♦ Did not receive allocated intervention  (n=0)
Analysed  (n=20) 




Randomized (n= 40) 
Enrollment 
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